Medical Marijuana for Neuropathy in Florida
Peripheral nerve damage causing numbness, tingling, and chronic pain.
Medically reviewed by Bruce Stratt, MD
Board-Certified Physician · OMMU Certified · Boca Raton, FL
Overview
Peripheral neuropathy occurs when nerves outside the brain and spinal cord become damaged, leading to pain, numbness, tingling, burning sensations, muscle weakness, and impaired coordination. It is one of the most common and difficult-to-treat pain conditions, affecting an estimated 20 million Americans. Neuropathy can result from diabetes (the most common cause), HIV/AIDS, chemotherapy, autoimmune diseases, vitamin deficiencies, alcoholism, physical injuries, and certain infections.
Conventional treatments for neuropathic pain include gabapentin, pregabalin, duloxetine, tricyclic antidepressants, and in severe cases, opioid analgesics. These medications often provide incomplete relief and carry side effects including drowsiness, dizziness, weight gain, and dependency. Many patients remain in significant pain despite trying multiple medications, making neuropathy a condition where alternative approaches are particularly valuable.
Neuropathy qualifies for medical marijuana in Florida under the chronic pain provision of Statute 381.986. It is one of the most well-studied conditions for medical cannabis, with multiple randomized controlled trials — the gold standard of clinical evidence — demonstrating significant benefit.
How Medical Cannabis May Help
Neuropathic pain is one of the most well-studied indications for medical cannabis, with multiple rigorous randomized controlled trials demonstrating significant benefit. A landmark RCT (Abrams et al., Neurology, 2007) studied 55 patients with HIV-associated sensory neuropathy and found that cannabis reduced daily pain by 34% vs. 17% with placebo (P=0.03), with 52% of cannabis patients achieving clinically meaningful pain reduction compared to 24% on placebo. A second RCT (Ellis et al., Neuropsychopharmacology, 2009) confirmed these results with an effect size of 0.60 — comparable to conventional neuropathic pain medications. The mechanism involves cannabinoid action on both CB1 receptors in the central nervous system (modulating pain perception in the dorsal horn of the spinal cord) and CB2 receptors in the peripheral nervous system (reducing local inflammation and nerve sensitization). Clinical studies have specifically shown that HIV-associated peripheral neuropathy, diabetic neuropathy, and chemotherapy-induced neuropathy all respond to medical cannabis treatment. Patients report reduced pain, improved sensation, better sleep, and enhanced overall functioning. Cannabis can serve as an alternative to or complement for conventional neuropathic pain medications, potentially allowing dose reductions of gabapentin, pregabalin, or opioids. For diabetic neuropathy specifically, high-CBD formulations are often recommended due to CBD's neuroprotective and anti-inflammatory properties. Topical cannabis products can address localized symptoms in the extremities, while oral forms provide systemic relief. Dr. Stratt evaluates each patient's neuropathy type and underlying cause to develop the most effective treatment approach.
Individual results vary. Consult with Dr. Stratt to understand how cannabis therapy may apply to your specific situation.
What to Bring to Your Appointment
Bring a valid Florida ID and neurology records, EMG/nerve conduction study results confirming neuropathy diagnosis, documentation of the underlying cause, and current medication list.
Frequently Asked Questions
Related Articles
Patient Resources
Get Your Medical Marijuana Card for Neuropathy
Schedule your evaluation with Dr. Stratt. Same-day state registry submissions for qualifying patients.